Chinese, Canadian Researchers ID Anti-Bird Flu Compound
This article was originally published in PharmAsia News
Executive Summary
Hong Kong and Canadian scientists working on a genome technology report found a compound that inhibits the H5N1 bird flu virus. The team said it tested 20 compounds and found one it labeled "compound-1" that inhibits neuraminidase involved in viral replication. The compound was found to operate at a level similar to oseltamivir, the active ingredient in Roche's Tamiflu, known to be losing its effectiveness against the virus. The identified compound was able to bind to the neuraminidase of the virus and, according to the researchers, might overcome the drug resistance. (Click here for more
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.